Chemistry meets biology in colitis-associated carcinogenesis

References

• Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066–2078.
   PubMed Web of Science ®Google Scholar
• Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011;140:1729–1737.
   PubMed Web of Science ®Google Scholar
• Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011;474:307–317.
   PubMed Web of Science ®Google Scholar
• Varol C, Zigmond E, Jung S. Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria. Nat Rev Immunol 2010;10:415–426.
   PubMed Web of Science ®Google Scholar
• Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell 2010;140:859–870.
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298–306.
   PubMed Web of Science ®Google Scholar
• Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101–2114.e5.
   PubMed Web of Science ®Google Scholar
• Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012;3:107.
   PubMed Web of Science ®Google Scholar
• Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119–124.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2010;6:339–346.
   PubMedGoogle Scholar
• Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood 2008;112:935–945.
   PubMed Web of Science ®Google Scholar
• Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006;6:173–182.
   PubMed Web of Science ®Google Scholar
• Weber B, Saurer L, Mueller C. Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. Semin Immunopathol 2009;31:171–184.
   PubMed Web of Science ®Google Scholar
• Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010;10:427–439.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011;11:519–531.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010;10: 479–489.
   PubMed Web of Science ®Google Scholar
• Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1756–1767.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357–359.
   PubMed Web of Science ®Google Scholar
• Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011;140:1807–1816.
   PubMed Web of Science ®Google Scholar
• Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009;457:608–611.
   PubMed Web of Science ®Google Scholar
• Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Goktuna SI, Ziegler PK, et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2012;152:25–38.
   Google Scholar
• Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276–85.
   PubMed Web of Science ®Google Scholar
• Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013;110:3507–3512.
   PubMed Web of Science ®Google Scholar
• Kolata G. Mice Fall Short as Test Subjects for Deadly Illnesses. The New York Times; 2013.
   Google Scholar
• Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, et al. CD4 + CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 2003;162:691–702.
   PubMed Web of Science ®Google Scholar
• Erdman SE, Rao VP, Poutahidis T, Rogers AB, Taylor CL, Jackson EA, et al. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A 2009;106:1027–1032.
   PubMed Web of Science ®Google Scholar
• Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, Prestwich E, et al. Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci U S A 2012;109:E1820–E1829.
   PubMed Web of Science ®Google Scholar
• Lu K, Knutson CG, Wishnok JS, Fox JG, Tannenbaum SR. Serum metabolomics in a Helicobacter hepaticus mouse model of inflammatory bowel disease reveal important changes in the microbiome, serum peptides, and intermediary metabolism. J Proteome Res 2012;11:4916–4926.
   PubMed Web of Science ®Google Scholar
• Knutson CG, Mangerich A, Zeng Y, Raczynski AR, Liberman RG, Kang P, et al. Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci U S A 2013;110:E2332–2341.
   PubMed Web of Science ®Google Scholar
• Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, Taylor NS, et al. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 1994;32:1238–1245.
   PubMed Web of Science ®Google Scholar
• Fox JG, Ge Z, Whary MT, Erdman SE, Horwitz BH. Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol 2011;4:22–30.
   PubMed Web of Science ®Google Scholar
• Shaked H, Hofseth LJ, Chumanevich A, Chumanevich AA, Wang J, Wang Y, et al. Chronic epithelial NF-kappaB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc Natl Acad Sci U S A 2012;109:14007–14012.
   PubMed Web of Science ®Google Scholar
• Hoffman RA, Zhang G, Nussler NC, Gleixner SL, Ford HR, Simmons RL, Watkins SC. Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am J Physiol 1997;272:G383–G392.
   PubMedGoogle Scholar
• Li CQ, Kim MY, Godoy LC, Thiantanawat A, Trudel LJ, Wogan GN. Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells. Proc Natl Acad Sci U S A 2009;106:14547–14551.
   Google Scholar
• Chin MP, Schauer DB, Deen WM. Nitric oxide, oxygen, and superoxide formation and consumption in macrophages and colonic epithelial cells. Chem Res Toxicol 2010;23: 778–787.
   Google Scholar
• Weitzman SA, Weitberg AB, Clark EP, Stossel TP. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 1985;227:1231–1233.
   PubMed Web of Science ®Google Scholar
• McCafferty DM, Mudgett JS, Swain MG, Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997;112:1022–1027.
   PubMed Web of Science ®Google Scholar
• McCafferty DM, Sihota E, Muscara M, Wallace JL, Sharkey KA, Kubes P. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol 2000;279:G90–G99.
   Google Scholar
• Zingarelli B, Szabo C, Salzman AL. Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut 1999;45: 199–209.
   PubMedGoogle Scholar
• Natsui M, Kawasaki K, Takizawa H, Hayashi SI, Matsuda Y, Sugimura K, et al. Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats. J Gastroenterol Hepatol 1997;12:801–808.
   PubMed Web of Science ®Google Scholar
• Muthupalani S, Ge Z, Feng Y, Rickman B, Mobley M, McCabe A, et al. Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine- mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2−/− mouse model of inflammatory bowel disease. Infect Immun 2012;80:4388–4397.
   Google Scholar
• Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 2008;4:278–286.
   PubMed Web of Science ®Google Scholar
• Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 2011; 10:453–471.
   PubMed Web of Science ®Google Scholar
• Vorbach C, Harrison R, Capecchi MR. Xanthine oxidoreductase is central to the evolution and function of the innate immune system. Trends Immunol 2003;24:512–517.
   PubMed Web of Science ®Google Scholar
• Rokutan K, Kawahara T, Kuwano Y, Tominaga K, Nishida K, Teshima-Kondo S. Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract. Semin Immunopathol 2008;30:315–327.
   PubMedGoogle Scholar
• Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E, et al. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 2005;207:164–176.
   PubMed Web of Science ®Google Scholar
• Fukuyama M, Rokutan K, Sano T, Miyake H, Shimada M, Tashiro S. Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett 2005;221:97–104.
   PubMedGoogle Scholar
• Kamizato M, Nishida K, Masuda K, Takeo K, Yamamoto Y, Kawai T, et al. Interleukin 10 inhibits interferon gamma- and tumor necrosis factor alpha-stimulated activation of NADPH oxidase 1 in human colonic epithelial cells and the mouse colon. J Gastroenterol 2009;44:1172–1184.
   PubMed Web of Science ®Google Scholar
• Kuwano Y, Tominaga K, Kawahara T, Sasaki H, Takeo K, Nishida K, et al. Tumor necrosis factor alpha activates transcription of the NADPH oxidase organizer 1 (NOXO1) gene and upregulates superoxide production in colon epithelial cells. Free Radic Biol Med 2008;45:1642–1652.
   PubMedGoogle Scholar
• Huang JS, Noack D, Rae J, Ellis BA, Newbury R, Pong AL, et al. Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease. Clin Gastroenterol Hepatol 2004;2:690–695.
   PubMedGoogle Scholar
• Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004; 114:462–468.
   PubMed Web of Science ®Google Scholar
• Gibbings S, Elkins ND, Fitzgerald H, Tiao J, Weyman ME, Shibao G, et al. Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}. J Biol Chem 2011;286:961–975.
   PubMed Web of Science ®Google Scholar
• Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003;201:28–36.
   PubMed Web of Science ®Google Scholar
• Vorbach C, Scriven A, Capecchi MR. The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating mammary gland. Genes Dev 2002;16:3223–3235.
   PubMed Web of Science ®Google Scholar
• Ohtsubo T, Matsumura K, Sakagami K, Fujii K, Tsuruya K, Noguchi H, et al. Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules. Hypertension 2009;54: 868–876.
   PubMed Web of Science ®Google Scholar
• Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, et al. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 2008;45:18–31.
   PubMed Web of Science ®Google Scholar
• Choi K, Chen J, Mitra S, Sarna SK. Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology 2011;141:1293–301, 1301 e1–3.
   Google Scholar
• Kruidenier L, van Meeteren ME, Kuiper I, Jaarsma D, Lamers CB, Zijlstra FJ, Verspaget HW. Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Radic Biol Med 2003;34:753–765.
   Google Scholar
• Weiss RH, Fretland DJ, Baron DA, Ryan US, Riley DP. Manganese-based superoxide dismutase mimetics inhibit neutrophil infiltration in vivo. J Biol Chem 1996;271: 26149–26156.
   PubMedGoogle Scholar
• Segui J, Gironella M, Sans M, Granell S, Gil F, Gimeno M, et al. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine. J Leukoc Biol 2004;76:537–544.
   PubMed Web of Science ®Google Scholar
• Oku T, Iyama S, Sato T, Sato Y, Tanaka M, Sagawa T, et al. Amelioration of murine dextran sulfate sodium-induced colitis by ex vivo extracellular superoxide dismutase gene transfer. Inflamm Bowel Dis 2006;12:630–640.
   Google Scholar
• Ishihara T, Tanaka K, Tasaka Y, Namba T, Suzuki J, Okamoto S, et al. Therapeutic effect of lecithinized superoxide dismutase against colitis. J Pharmacol Exp Ther 2009; 328:152–164.
   PubMed Web of Science ®Google Scholar
• Kruidenier L, Kuiper I, van Duijn W, Marklund SL, van Hogezand RA, Lamers CB, Verspaget HW. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. J Pathol 2003;201:7–16.
   PubMed Web of Science ®Google Scholar
• Lewis RS, Tamir S, Tannenbaum SR, Deen WM. Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro. J Biol Chem 1995;270: 29350–29355.
   PubMed Web of Science ®Google Scholar
• Tannenbaum SR, Fett D, Young VR, Land PD, Bruce WR. Nitrite and nitrate are formed by endogenous synthesis in the human intestine. Science 1978;200:1487–1489.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Weitzberg E, Gladwin MT. The nitrate- nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008;7:156–167.
   PubMed Web of Science ®Google Scholar
• Bryan NS, Fernandez BO, Bauer SM, Garcia-Saura MF, Milsom AB, Rassaf T, et al. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol 2005;1:290–297.
   PubMed Web of Science ®Google Scholar
• Ferrer-Sueta G, Radi R. Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. ACS Chem Biol 2009;4: 161–177.
   PubMed Web of Science ®Google Scholar
• Lonkar P, Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer 2010.
   Google Scholar
• Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988;27: 8706–8711.
   PubMed Web of Science ®Google Scholar
• Stuehr DJ, Santolini J, Wang ZQ, Wei CC, Adak S. Update on mechanism and catalytic regulation in the NO synthases. J Biol Chem 2004;279:36167–36170.
   PubMed Web of Science ®Google Scholar
• Chin MP, Schauer DB, Deen WM. Prediction of nitric oxide concentrations in colonic crypts during inflammation. Nitric Oxide 2008;19:266–275.
   PubMed Web of Science ®Google Scholar
• Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998;42:180–187.
   PubMed Web of Science ®Google Scholar
• Singer, II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996;111: 871–885.
   PubMed Web of Science ®Google Scholar
• Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987;84:9265–9269.
   PubMed Web of Science ®Google Scholar
• Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524–526.
   PubMed Web of Science ®Google Scholar
• MacNaughton WK, Lowe SS, Cushing K. Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis. Am J Physiol 1998;275: G1353–G1360.
   Web of Science ®Google Scholar
• Hokari R, Kato S, Matsuzaki K, Kuroki M, Iwai A, Kawaguchi A, et al. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med 2001;31:153–163.
   PubMed Web of Science ®Google Scholar
• Yasukawa K, Tokuda H, Tun X, Utsumi H, Yamada KI. The detrimental effect of nitric oxide on tissue is associated with inflammatory events in the vascular endothelium and neutrophils in mice with dextran sodium sulfate-induced colitis. Free Radic Res 2012;46:1427–1436.
   PubMed Web of Science ®Google Scholar
• Saijo F, Milsom AB, Bryan NS, Bauer SM, Vowinkel T, Ivanovic M, et al. On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease. Nitric Oxide 2010;22:155–167.
   Google Scholar
• Kohno H, Takahashi M, Yasui Y, Suzuki R, Miyamoto S, Kamanaka Y, et al. A specific inducible nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice. Int J Cancer 2007;121:506–513.
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, et al. Peroxynitrite-induced rat colitis–a new model of colonic inflammation. Gastroenterology 1993;105:1681–1688.
   PubMed Web of Science ®Google Scholar
• Ahn B, Ohshima H. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res 2001;61:8357–8360.
   PubMed Web of Science ®Google Scholar
• Krieglstein CF, Anthoni C, Cerwinka WH, Stokes KY, Russell J, Grisham MB, Granger DN. Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation. Am J Pathol 2007;170:490–496.
   Google Scholar
• Beck PL, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A, et al. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am J Physiol Gastrointest Liver Physiol 2004;286:G137–G147.
   PubMed Web of Science ®Google Scholar
• Seril DN, Liao J, Yang GY. Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis. Mol Carcinog 2007;46:341–353.
   Google Scholar
• Zhang R, Ma A, Urbanski SJ, McCafferty DM. Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma. Carcinogenesis 2007;28: 1122–1130.
   Google Scholar
• Beck PL, Li Y, Wong J, Chen CW, Keenan CM, Sharkey KA, McCafferty DM. Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation. Gastroenterology 2007;132:1778–1790.
   PubMed Web of Science ®Google Scholar
• Schneemann M, Schoedon G. Species differences in macrophage NO production are important. Nat Immunol 2002;3:102.
   PubMed Web of Science ®Google Scholar
• Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172:2731–2738.
   PubMed Web of Science ®Google Scholar
• Fang FC, Nathan CF. Man is not a mouse: reply. J Leukoc Biol 2007;81:580.
   Google Scholar
• Schneemann M, Schoeden G. Macrophage biology and immunology: man is not a mouse. J Leukoc Biol 2007;81:579; discussion 580.
   Web of Science ®Google Scholar
• Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJ, Moncada S. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993;342:338–340.
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995;36:718–723.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, Fields JZ. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 2003; 52:720–728.
   PubMed Web of Science ®Google Scholar
• Gochman E, Mahajna J, Shenzer P, Dahan A, Blatt A, Elyakim R, Reznick AZ. The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans. Acta Histochem 2012;114:827–835.
   PubMed Web of Science ®Google Scholar
• Yue G, Lai PS, Yin K, Sun FF, Nagele RG, Liu X, et al. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J Pharmacol Exp Ther 2001;297:915–925.
   PubMed Web of Science ®Google Scholar
• Guihot G, Guimbaud R, Bertrand V, Narcy-Lambare B, Couturier D, Duee PH, et al. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease. Amino Acids 2000;18:229–237.
   PubMed Web of Science ®Google Scholar
• Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I, et al. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci 1997;42:1047–1054.
   Google Scholar
• van der Veen BS, de Winther MP, Heeringa P. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 2009;11:2899–2937.
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005;77:598–625.
   PubMed Web of Science ®Google Scholar
• Pattison DI, Davies MJ, Hawkins CL. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids. Free Radic Res 2012;46:975–995.
   PubMed Web of Science ®Google Scholar
• Arnhold J, Flemmig J. Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys 2010;500: 92–106.
   PubMed Web of Science ®Google Scholar
• McBee ME, Zeng Y, Parry N, Nagler CR, Tannenbaum SR, Schauer DB. Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis. PLoS ONE 2010;5:e13277.
   Web of Science ®Google Scholar
• Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide- derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393–397.
   PubMed Web of Science ®Google Scholar
• Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, et al. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002;277:17415–17427.
   PubMed Web of Science ®Google Scholar
• Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, et al. Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 2002;109:1311–1319.
   PubMed Web of Science ®Google Scholar
• Brennan ML, Anderson MM, Shih DM, Qu XD, Wang X, Mehta AC, et al. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 2001;107:419–430.
   PubMed Web of Science ®Google Scholar
• Takizawa S, Aratani Y, Fukuyama N, Maeda N, Hirabayashi H, Koyama H, et al. Deficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain. J Cereb Blood Flow Metab 2002;22:50–54.
   Google Scholar
• Garrity-Park M, Loftus EV Jr, Sandborn WJ, Smyrk TC. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation. Inflamm Bowel Dis 2012;18:275–283.
   Google Scholar
• Ardite E, Sans M, Panes J, Romero FJ, Pique JM, Fernandez-Checa JC. Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest 2000;80:735–744.
   PubMed Web of Science ®Google Scholar
• Seril DN, Liao J, Ho KL, Yang CS, Yang GY. Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis 2002;23:993–1001.
   PubMed Web of Science ®Google Scholar
• Catarzi S, Favilli F, Romagnoli C, Marcucci T, Picariello L, Tonelli F, et al. Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn's disease patients. Inflamm Bowel Dis 2011;17:1674–1684.
   Google Scholar
• Murawaki Y, Tsuchiya H, Kanbe T, Harada K, Yashima K, Nozaka K, et al. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett 2008; 259:218–230.
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. Intestinal redox biology and oxidative stress. Semin Cell Dev Biol 2012;23:729–737.
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohe R, Kipp AP. Physiological functions of GPx2 and its role in inflammation-triggered carcinogenesis. Ann N Y Acad Sci 2012;1259:19–25.
   PubMed Web of Science ®Google Scholar
• Te Velde AA, Pronk I, de Kort F, Stokkers PC. Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2?Eur J Gastroenterol Hepatol 2008;20:555–560.
   Google Scholar
• Krehl S, Loewinger M, Florian S, Kipp AP, Banning A, Wessjohann LA, et al. Glutathione peroxidase-2 and selenium decreased inflammation and tumors in a mouse model of inflammation-associated carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcinogenesis 2012;33:620–628.
   PubMed Web of Science ®Google Scholar
• Florian S, Krehl S, Loewinger M, Kipp A, Banning A, Esworthy S, et al. Loss of GPx2 increases apoptosis, mitosis, and GPx1 expression in the intestine of mice. Free Radic Biol Med 2010;49:1694–1702.
   PubMed Web of Science ®Google Scholar
• Esworthy RS, Aranda R, Martin MG, Doroshow JH, Binder SW, Chu FF. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 2001;281:G848–G855.
   PubMed Web of Science ®Google Scholar
• Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009;284:13291–13295.
   PubMed Web of Science ®Google Scholar
• Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005;6:150–166.
   PubMed Web of Science ®Google Scholar
• Tannenbaum SR, Kim JE. Controlled S-nitrosation. Nat Chem Biol 2005;1:126–127.
   Google Scholar
• Barglow KT, Knutson CG, Wishnok JS, Tannenbaum SR, Marletta MA. Site-specific and redox-controlled S-nitrosation of thioredoxin. Proc Natl Acad Sci U S A 2011;108: E600–E606.
   Google Scholar
• Mitchell DA, Morton SU, Fernhoff NB, Marletta MA. Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proc Natl Acad Sci U S A 2007;104:11609–11614.
   PubMed Web of Science ®Google Scholar
• Mitchell DA, Marletta MA. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol 2005;1:154–158.
   Google Scholar
• Khor TO, Huang MT, Prawan A, Liu Y, Hao X, Yu S, et al. Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev Res (Phila) 2008; 1:187–191.
   PubMed Web of Science ®Google Scholar
• Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 2006;66:11580–11584.
   PubMed Web of Science ®Google Scholar
• Osburn WO, Karim B, Dolan PM, Liu G, Yamamoto M, Huso DL, Kensler TW. Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment. Int J Cancer 2007;121:1883–1891.
   PubMedGoogle Scholar
• Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. Nrf2 gene promoter polymorphism is associated with ulcerative colitis in a Japanese population. Hepatogastroenterology 2008;55:394–397.
   PubMedGoogle Scholar
• Jin Y, Kotakadi VS, Ying L, Hofseth AB, Cui X, Wood PA, et al. American ginseng suppresses inflammation and DNA damage associated with mouse colitis. Carcinogenesis 2008;29:2351–2359.
   PubMed Web of Science ®Google Scholar
• Ju J, Hao X, Lee MJ, Lambert JD, Lu G, Xiao H, et al. A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice. Cancer Prev Res (Phila) 2009;2:143–152.
   PubMed Web of Science ®Google Scholar
• Hao X, Sun Y, Yang CS, Bose M, Lambert JD, Ju J, et al. Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins. Nutr Cancer 2007;59:62–69.
   PubMed Web of Science ®Google Scholar
• Vong LB, Tomita T, Yoshitomi T, Matsui H, Nagasaki Y. An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice. Gastroenterology 2012;143:1027–1036.e3.
   PubMed Web of Science ®Google Scholar
• Dong M, Dedon PC. Relatively small increases in the steady-state levels of nucleobase deamination products in DNA from human TK6 cells exposed to toxic levels of nitric oxide. Chem Res Toxicol 2006;19:50–57.
   PubMed Web of Science ®Google Scholar
• Li CQ, Pang B, Kiziltepe T, Trudel LJ, Engelward BP, Dedon PC, Wogan GN. Threshold effects of nitric oxide-induced toxicity and cellular responses in wild-type and p53-null human lymphoblastoid cells. Chem Res Toxicol 2006;19:399–406.
   PubMed Web of Science ®Google Scholar
• Skinn BT, Lim CH, Deen WM. Nitric oxide delivery system for biological media. Free Radic Biol Med 2011; 50:381–388.
   Google Scholar
• Wang C, Deen WM. Peroxynitrite delivery methods for toxicity studies. Chem Res Toxicol 2004;17:32–44.
   Google Scholar
• Dendroulakis V, Russell BS, Elmquist CE, Trudel LJ, Wogan GN, Deen WM, Dedon PC. A system for exposing molecules and cells to biologically relevant and accurately controlled steady-state concentrations of nitric oxide and oxygen. Nitric Oxide 2012;27:161–168.
   Google Scholar
• Skinn BT, Deen WM. Nitrogen dioxide delivery system for biological media. Free Radic Biol Med 2012.
   Google Scholar
• Wang C, Trudel LJ, Wogan GN, Deen WM. Thresholds of nitric oxide-mediated toxicity in human lymphoblastoid cells. Chem Res Toxicol 2003;16:1004–1013.
   Google Scholar
• Zhuang JC, Wogan GN. Growth and viability of macrophages continuously stimulated to produce nitric oxide. Proc Natl Acad Sci U S A 1997;94:11875–11880.
   PubMedGoogle Scholar
• Zhuang JC, Lin D, Lin C, Jethwaney D, Wogan GN. Genotoxicity associated with NO production in macrophages and co-cultured target cells. Free Radic Biol Med 2002;33: 94–102.
   Google Scholar
• Li CQ, Wogan GN. Nitric oxide as a modulator of apoptosis. Cancer Lett 2005;226:1–15.
   PubMed Web of Science ®Google Scholar
• Burney S, Tamir S, Gal A, Tannenbaum SR. A mechanistic analysis of nitric oxide-induced cellular toxicity. Nitric Oxide 1997;1:130–144.
   PubMed Web of Science ®Google Scholar
• Niles JC, Wishnok JS, Tannenbaum SR. Peroxynitrite- induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation. Nitric Oxide 2006;14:109–121.
   PubMed Web of Science ®Google Scholar
• Neeley WL, Essigmann JM. Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products. Chem Res Toxicol 2006;19:491–505.
   PubMed Web of Science ®Google Scholar
• Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004;423:12–22.
   PubMed Web of Science ®Google Scholar
• Dong M, Wang C, Deen WM, Dedon PC. Absence of 2’-deoxyoxanosine and presence of abasic sites in DNA exposed to nitric oxide at controlled physiological concentrations. Chem Res Toxicol 2003;16:1044–1055.
   PubMed Web of Science ®Google Scholar
• Glaser R, Wu H, Lewis M. Cytosine catalysis of nitrosative guanine deamination and interstrand cross-link formation. J Am Chem Soc 2005;127:7346–7358.
   PubMed Web of Science ®Google Scholar
• Son J, Pang B, McFaline JL, Taghizadeh K, Dedon PC. Surveying the damage: the challenges of developing nucleic acid biomarkers of inflammation. Mol Biosyst 2008;4: 902–908.
   PubMed Web of Science ®Google Scholar
• deRojas-Walker T, Tamir S, Ji H, Wishnok JS, Tannenbaum SR. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem Res Toxicol 1995;8:473–477.
   PubMed Web of Science ®Google Scholar
• Tretyakova NY, Burney S, Pamir B, Wishnok JS, Dedon PC, Wogan GN, Tannenbaum SR. Peroxynitrite-induced DNA damage in the supF gene: correlation with the mutational spectrum. Mutat Res 2000;447:287–303.
   PubMed Web of Science ®Google Scholar
• Cui L, Ye W, Prestwich EG, Wishnok JS, Taghizadeh K, Dedon PC, Tannenbaum SR. Comparative analysis of four oxidized guanine lesions from reactions of DNA with peroxynitrite, singlet oxygen, and gamma-radiation. Chem Res Toxicol 2013;26:195–202.
   PubMed Web of Science ®Google Scholar
• Margolin Y, Shafirovich V, Geacintov NE, DeMott MS, Dedon PC. DNA sequence context as a determinant of the quantity and chemistry of guanine oxidation produced by hydroxyl radicals and one-electron oxidants. J Biol Chem 2008;283:35569–35578.
   Google Scholar
• Margolin Y, Cloutier JF, Shafirovich V, Geacintov NE, Dedon PC. Paradoxical hotspots for guanine oxidation by a chemical mediator of inflammation. Nat Chem Biol 2006;2:365–366.
   PubMed Web of Science ®Google Scholar
• Burney S, Niles JC, Dedon PC, Tannenbaum SR. DNA damage in deoxynucleosides and oligonucleotides treated with peroxynitrite. Chem Res Toxicol 1999;12:513–520.
   PubMedGoogle Scholar
• Shen Z, Wu W, Hazen SL. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry 2000;39:5474–5482.
   PubMed Web of Science ®Google Scholar
• Byun J, Henderson JP, Mueller DM, Heinecke JW. 8-Nitro-2’-deoxyguanosine, a specific marker of oxidation by reactive nitrogen species, is generated by the myeloperoxidase-hydrogen peroxide-nitrite system of activated human phagocytes. Biochemistry 1999;38:2590–2600.
   Google Scholar
• Luo W, Muller JG, Rachlin EM, Burrows CJ. Characterization of hydantoin products from one-electron oxidation of 8-oxo-7,8-dihydroguanosine in a nucleoside model. Chem Res Toxicol 2001;14:927–938.
   PubMed Web of Science ®Google Scholar
• Luo W, Muller JG, Rachlin EM, Burrows CJ. Characterization of spiroiminodihydantoin as a product of one-electron oxidation of 8-Oxo-7,8-dihydroguanosine. Org Lett 2000; 2:613–616.
   PubMed Web of Science ®Google Scholar
• Yu H, Venkatarangan L, Wishnok JS, Tannenbaum SR. Quantitation of four guanine oxidation products from reaction of DNA with varying doses of peroxynitrite. Chem Res Toxicol 2005;18:1849–1857.
   PubMed Web of Science ®Google Scholar
• Niles JC, Wishnok JS, Tannenbaum SR. Spiroiminodihydantoin and guanidinohydantoin are the dominant products of 8-oxoguanosine oxidation at low fluxes of peroxynitrite: mechanistic studies with 18O. Chem Res Toxicol 2004; 17:1510–1519.
   PubMed Web of Science ®Google Scholar
• Nakabeppu Y, Sakumi K, Sakamoto K, Tsuchimoto D, Tsuzuki T, Nakatsu Y. Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids. Biol Chem 2006; 387:373–379.
   PubMed Web of Science ®Google Scholar
• Henderson PT, Delaney JC, Muller JG, Neeley WL, Tannenbaum SR, Burrows CJ, Essigmann JM. The hydantoin lesions formed from oxidation of 7,8-dihydro-8-oxoguanine are potent sources of replication errors in vivo. Biochemistry 2003;42:9257–9262.
   PubMed Web of Science ®Google Scholar
• van Loon B, Markkanen E, Hübscher U. Oxygen as a friend and enemy: how to combat the mutational potential of 8-oxo-guanine. DNA Repair 2010;9:604–616.
   PubMed Web of Science ®Google Scholar
• Ding X, Hiraku Y, Ma N, Kato T, Saito K, Nagahama M, et al. Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci 2005;96:157–163.
   PubMed Web of Science ®Google Scholar
• Westbrook AM, Wei B, Braun J, Schiestl RH. Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res 2009;69:4827–4834.
   PubMed Web of Science ®Google Scholar
• McKenzie SJ, Baker MS, Buffinton GD, Doe WF. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996;98:136–141.
   PubMed Web of Science ®Google Scholar
• D’Inca R, Cardin R, Benazzato L, Angriman I, Martines D, Sturniolo GC. Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm Bowel Dis 2004;10:23–27.
   PubMed Web of Science ®Google Scholar
• Choi J, Yoon SH, Kim JE, Rhee KH, Youn HS, Chung MH. Gene-specific oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Int J Cancer 2002; 99:485–490.
   Google Scholar
• O’Hagan HM, Wang W, Sen S, Destefano Shields C, Lee SS, Zhang YW, et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell 2011;20: 606–619.
   PubMed Web of Science ®Google Scholar
• Winczura A, Zdzalik D, Tudek B. Damage of DNA and proteins by major lipid peroxidation products in genome stability. Free Radic Res 2012;46:442–459.
   PubMed Web of Science ®Google Scholar
• Pang B, Zhou X, Yu H, Dong M, Taghizadeh K, Wishnok JS, et al. Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation. Carcinogenesis 2007;28:1807–1813.
   PubMedGoogle Scholar
• Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 2008;118:2516–2525.
   PubMed Web of Science ®Google Scholar
• Nair J, Gansauge F, Beger H, Dolara P, Winde G, Bartsch H. Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis. Antioxid Redox Signal 2006;8:1003–1010.
   PubMed Web of Science ®Google Scholar
• Bartsch H, Nair J. Potential role of lipid peroxidation derived DNA damage in human colon carcinogenesis: studies on exocyclic base adducts as stable oxidative stress markers. Cancer Detect Prev 2002;26:308–312.
   PubMedGoogle Scholar
• Nair U, Bartsch H, Nair J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med 2007;43:1109–1120.
   PubMed Web of Science ®Google Scholar
• Zhang R, Brennan ML, Shen Z, MacPherson JC, Schmitt D, Molenda CE, Hazen SL. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 2002;277: 46116–46122.
   PubMed Web of Science ®Google Scholar
• Godschalk RW, Albrecht C, Curfs DM, Schins RP, Bartsch H, van Schooten FJ, Nair J. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice. Mutat Res 2007;621:87–94.
   PubMed Web of Science ®Google Scholar
• Obtulowicz T, Winczura A, Speina E, Swoboda M, Janik J, Janowska B, et al. Aberrant repair of etheno-DNA adducts in leukocytes and colon tissue of colon cancer patients. Free Radic Biol Med 2010;49:1064–1071.
   PubMedGoogle Scholar
• Asahi T, Kondo H, Masuda M, Nishino H, Aratani Y, Naito Y, et al. Chemical and immunochemical detection of 8-halogenated deoxyguanosines at early stage inflammation. J Biol Chem 2010;285:9282–9291.
   PubMed Web of Science ®Google Scholar
• Kawai Y, Morinaga H, Kondo H, Miyoshi N, Nakamura Y, Uchida K, Osawa T. Endogenous formation of novel halogenated 2’-deoxycytidine. Hypohalous acid-mediated DNA modification at the site of inflammation. J Biol Chem 2004;279:51241–51249.
   PubMed Web of Science ®Google Scholar
• Henderson JP, Byun J, Takeshita J, Heinecke JW. Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. J Biol Chem 2003;278:23522–23528.
   PubMed Web of Science ®Google Scholar
• Masuda M, Suzuki T, Friesen MD, Ravanat JL, Cadet J, Pignatelli B, et al. Chlorination of guanosine and other nucleosides by hypochlorous acid and myeloperoxidase of activated human neutrophils. Catalysis by nicotine and trimethylamine. J Biol Chem 2001;276:40486–40496.
   PubMed Web of Science ®Google Scholar
• Henderson JP, Byun J, Heinecke JW. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA. J Biol Chem 1999;274:33440–33448.
   PubMed Web of Science ®Google Scholar
• Badouard C, Masuda M, Nishino H, Cadet J, Favier A, Ravanat JL. Detection of chlorinated DNA and RNA nucleosides by HPLC coupled to tandem mass spectrometry as potential biomarkers of inflammation. J Chromatogr B Analyt Technol Biomed Life Sci 2005;827:26–31.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Blount BC, Ames BN. 5-Chlorouracil, a marker of DNA damage from hypochlorous acid during inflammation. A gas chromatography-mass spectrometry assay. J Biol Chem 2003;278:32834–32840.
   Google Scholar
• Takeshita J, Byun J, Nhan TQ, Pritchard DK, Pennathur S, Schwartz SM, et al. Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue: a potential pathway for somatic mutagenesis by macrophages. J Biol Chem 2006; 281:3096–3104.
   PubMed Web of Science ®Google Scholar
• Valinluck V, Liu P, Kang JI Jr, Burdzy A, Sowers LC. 5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2). Nucleic Acids Res 2005;33:3057–3064.
   PubMedGoogle Scholar
• Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 2007;67:946–950.
   PubMed Web of Science ®Google Scholar
• Lao VV, Herring JL, Kim CH, Darwanto A, Soto U, Sowers LC. Incorporation of 5-chlorocytosine into mammalian DNA results in heritable gene silencing and altered cytosine methylation patterns. Carcinogenesis 2009; 30:886–893.
   Google Scholar
• Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001;61:3573–3577.
   PubMed Web of Science ®Google Scholar
• London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 1997; 57:5001–5003.
   PubMed Web of Science ®Google Scholar
• Cascorbi I, Henning S, Brockmoller J, Gephart J, Meisel C, Muller JM, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant–463A of the myeloperoxidase gene. Cancer Res 2000;60:644–649.
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Seifried A, Lum A, Wilkens LR. Association of the myeloperoxidase -463G–> a polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:181–184.
   PubMed Web of Science ®Google Scholar
• Kozekov ID, Nechev LV, Moseley MS, Harris CM, Rizzo CJ, Stone MP, Harris TM. DNA interchain cross-links formed by acrolein and crotonaldehyde. J Am Chem Soc 2003;125:50–61.
   PubMed Web of Science ®Google Scholar
• Stone MP, Cho YJ, Huang H, Kim HY, Kozekov ID, Kozekova A, et al. Interstrand DNA cross-links induced by alpha,beta-unsaturated aldehydes derived from lipid peroxidation and environmental sources. Acc Chem Res 2008;41:793–804.
   PubMed Web of Science ®Google Scholar
• Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer 2011;11:467–480.
   PubMed Web of Science ®Google Scholar
• Caulfield JL, Wishnok JS, Tannenbaum SR. Nitric oxide-induced interstrand cross-links in DNA. Chem Res Toxicol 2003;16:571–574.
   Google Scholar
• Burney S, Caulfield JL, Niles JC, Wishnok JS, Tannenbaum SR. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res 1999;424:37–49.
   PubMed Web of Science ®Google Scholar
• Kiziltepe T, Yan A, Dong M, Jonnalagadda VS, Dedon PC, Engelward BP. Delineation of the chemical pathways underlying nitric oxide-induced homologous recombination in mammalian cells. Chem Biol 2005;12:357–369.
   Google Scholar
• Yang Q, Dong Y, Wu W, Zhu C, Chong H, Lu J, et al. Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation. Nat Commun 2012;3:1206.
   Google Scholar
• Kriegl L, Neumann J, Vieth M, Greten FR, Reu S, Jung A, Kirchner T. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod Pathol 2011;24:1015–1022.
   Google Scholar
• Wang FY, Arisawa T, Tahara T, Takahama K, Watanabe M, Hirata I, Nakano H. Aberrant DNA methylation in ulcerative colitis without neoplasia. Hepatogastroenterology 2008;55: 62–65.
   PubMedGoogle Scholar
• Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998;58: 3942–3945.
   PubMed Web of Science ®Google Scholar
• Westbrook AM, Wei B, Braun J, Schiestl RH. Intestinal inflammation induces genotoxicity to extraintestinal tissues and cell types in mice. Int J Cancer 2011;129:1815–1825.
   PubMed Web of Science ®Google Scholar
• Kang MH, Genser D, Elmadfa I. Increased sister chromatid exchanges in peripheral lymphocytes of patients with Crohn's disease. Mutat Res 1997;381:141–148.
   PubMed Web of Science ®Google Scholar
• Rabinovitch PS, Dziadon S, Brentnall TA, Emond MJ, Crispin DA, Haggitt RC, Bronner MP. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999;59:5148–5153.
   PubMedGoogle Scholar
• O’Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002;32:280–284.
   PubMedGoogle Scholar
• Risques RA, Lai LA, Himmetoglu C, Ebaee A, Li L, Feng Z, et al. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res 2011;71:1669–1679.
   PubMed Web of Science ®Google Scholar
• Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, Gallaher J, et al. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 2008;135:410–418.
   PubMed Web of Science ®Google Scholar
• von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?Exp Cell Res 1995; 220:186–193.
   PubMed Web of Science ®Google Scholar
• Kohonen-Corish MR, Daniel JJ, te Riele H, Buffinton GD, Dahlstrom JE. Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors. Cancer Res 2002; 62:2092–2097.
   Google Scholar
• Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996;56:1237–1240.
   PubMed Web of Science ®Google Scholar
• Liao J, Seril DN, Lu GG, Zhang M, Toyokuni S, Yang AL, Yang GY. Increased susceptibility of chronic ulcerative colitis-induced carcinoma development in DNA repair enzyme Ogg1 deficient mice. Mol Carcinog 2008;47:638–646.
   PubMed Web of Science ®Google Scholar
• Calvo JA, Meira LB, Lee CY, Moroski-Erkul CA, Abolhassani N, Taghizadeh K, et al. DNA repair is indispensable for survival after acute inflammation. J Clin Invest 2012;122:2680.
   Google Scholar
• Hofseth LJ, Khan MA, Ambrose M, Nikolayeva O, Xu-Welliver M, Kartalou M, et al. The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J Clin Invest 2003; 112:1887–1894.
   PubMedGoogle Scholar
• Mutamba JT, Svilar D, Prasongtanakij S, Wang XH, Lin YC, et al. XRCC1 and base excision repair balance in response to nitric oxide. DNA Repair (Amst) 2011;10: 1282–1293.
   PubMedGoogle Scholar
• Machado AM, Figueiredo C, Touati E, Maximo V, Sousa S, Michel V, et al. Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin Cancer Res 2009;15:2995–3002.
   PubMed Web of Science ®Google Scholar
• Fleisher AS, Esteller M, Harpaz N, Leytin A, Rashid A, Xu Y, et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res 2000; 60:4864–4868.
   PubMed Web of Science ®Google Scholar
• Edwards RA, Witherspoon M, Wang K, Afrasiabi K, Pham T, Birnbaumer L, Lipkin SM. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. Cancer Res 2009;69:6423–6429.
   PubMed Web of Science ®Google Scholar
• Graziewicz M, Wink DA, Laval F. Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage. Carcinogenesis 1996;17:2501–2505.
   PubMed Web of Science ®Google Scholar
• Laval F, Wink DA. Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis 1994;15:443–447.
   PubMed Web of Science ®Google Scholar
• Sidorkina O, Espey MG, Miranda KM, Wink DA, Laval J. Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free Radic Biol Med 2003;35:1431–1438.
   Google Scholar
• Wu X, Takenaka K, Sonoda E, Hochegger H, Kawanishi S, Kawamoto T, et al. Critical roles for polymerase zeta in cellular tolerance to nitric oxide-induced DNA damage. Cancer Res 2006;66:748–754.
   PubMed Web of Science ®Google Scholar
• Chang CL, Marra G, Chauhan DP, Ha HT, Chang DK, Ricciardiello L, et al. Oxidative stress inactivates the human DNA mismatch repair system. Am J Physiol Cell Physiol 2002;283:C148–C154.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Tao H, Carloni E, Leung WK, Graham DY, Sepulveda AR. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 2002; 123:542–553.
   Google Scholar
• Westbrook AM, Schiestl RH. Atm-deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation. Cancer Res 2010;70:1875–1884.
   Google Scholar
• Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci U S A 2003;100:143–148.
   PubMed Web of Science ®Google Scholar
• Fujii S, Fujimori T, Kawamata H, Takeda J, Kitajima K, Omotehara F, et al. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 2004;53:710–716.
   PubMed Web of Science ®Google Scholar
• Yin J, Harpaz N, Tong Y, Huang Y, Laurin J, Greenwald BD, et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993;104: 1633–1639.
   PubMed Web of Science ®Google Scholar
• Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, et al. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 1992;103:1602–1610.
   PubMed Web of Science ®Google Scholar
• Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, et al. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992;52:741–745.
   Google Scholar
• Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, Burmer GC. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369–378.
   PubMed Web of Science ®Google Scholar
• Harpaz N, Peck AL, Yin J, Fiel I, Hontanosas M, Tong TR, et al. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 1994; 25:1069–1074.
   PubMedGoogle Scholar
• Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000;60:3333–3337.
   PubMed Web of Science ®Google Scholar
• Zhuang JC, Wright TL, deRojas-Walker T, Tannenbaum SR, Wogan GN. Nitric oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium. Environ Mol Mutagen 2000;35:39–47.
   Google Scholar
• Li CQ, Trudel LJ, Wogan GN. Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53. Proc Natl Acad Sci U S A 2002;99:10364–10369.
   PubMedGoogle Scholar
• Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 1992;89:3030–3034.
   PubMed Web of Science ®Google Scholar
• Kim MY, Lim CH, Trudel LJ, Deen WM, Wogan GN. Delivery method, target gene structure, and growth properties of target cells impact mutagenic responses to reactive nitrogen and oxygen species. Chem Res Toxicol 2012;25:873–883.
   Google Scholar
• Sheh A, Lee CW, Masumura K, Rickman BH, Nohmi T, Wogan GN, et al. Mutagenic potency of Helicobacter pylori in the gastric mucosa of mice is determined by sex and duration of infection. Proc Natl Acad Sci U S A 2010; 107:15217–15222.
   Google Scholar
• Sato Y, Takahashi S, Kinouchi Y, Shiraki M, Endo K, Matsumura Y, et al. IL-10 deficiency leads to somatic mutations in a model of IBD. Carcinogenesis 2006;27: 1068–1073.
   PubMed Web of Science ®Google Scholar
• Redston MS, Papadopoulos N, Caldas C, Kinzler KW, Kern SE. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 1995;108:383–392.
   PubMed Web of Science ®Google Scholar
• Goodman JE, Hofseth LJ, Hussain SP, Harris CC. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 2004;44:3–9.
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Wang TC. Cancer. Bacteria deliver a genotoxic hit. Science 2012;338:52–53.
   Google Scholar
• Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol 2013; 35:229–244.
   PubMed Web of Science ®Google Scholar
• Wang X, Yang Y, Moore DR, Nimmo SL, Lightfoot SA, Huycke MM. 4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. Gastroenterology 2012;142:543–551.e7.
   PubMed Web of Science ®Google Scholar
• Huycke MM, Moore D, Joyce W, Wise P, Shepard L, Kotake Y, Gilmore MS. Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol Microbiol 2001;42:729–740.
   PubMed Web of Science ®Google Scholar
• Wang X, Huycke MM. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 2007;132:551–561.
   PubMed Web of Science ®Google Scholar
• Huycke MM, Moore DR. In vivo production of hydroxyl radical by Enterococcus faecalis colonizing the intestinal tract using aromatic hydroxylation. Free Radic Biol Med 2002;33:818–826.
   PubMed Web of Science ®Google Scholar
• Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 2010;107:11537–11542.
   PubMed Web of Science ®Google Scholar
• Nougayrede JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006;313:848–851.
   PubMed Web of Science ®Google Scholar
• Ge Z, Rogers AB, Feng Y, Lee A, Xu S, Taylor NS, Fox JG. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 2007;9:2070–2080.
   PubMed Web of Science ®Google Scholar
• Guidi R, Guerra L, Levi L, Stenerlow B, Fox JG, Josenhans C, et al. Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response. Cell Microbiol 2013;15:98–113.
   PubMed Web of Science ®Google Scholar
• Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012; 338:120–123.
   PubMed Web of Science ®Google Scholar
• Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013;339:708–711.
   PubMed Web of Science ®Google Scholar
• Venkatesan BM, Bashir R. Nanopore sensors for nucleic acid analysis. Nat Nanotechnol 2011;6:615–624.
   PubMed Web of Science ®Google Scholar
• Schibel AE, An N, Jin Q, Fleming AM, Burrows CJ, White HS. Nanopore detection of 8-oxo-7,8-dihydro-2’-deoxyguanosine in immobilized single-stranded DNA via adduct formation to the DNA damage site. J Am Chem Soc 2010;132:17992–17995.
   PubMed Web of Science ®Google Scholar
• Korzenik JR, Podolsky DK. Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov 2006;5:197–209.
   PubMed Web of Science ®Google Scholar
• Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005;206:260–276.
   PubMed Web of Science ®Google Scholar
• Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 2007;59:1073–1083.
   PubMed Web of Science ®Google Scholar
• Westbrook AM, Szakmary A, Schiestl RH. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res 2010;705:40–59.
   PubMed Web of Science ®Google Scholar
• Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007;2:541–546.
   PubMed Web of Science ®Google Scholar
• Neufert C, Becker C, Neurath MF. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2007;2:1998–2004.
   PubMed Web of Science ®Google Scholar
• Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263–274.
   PubMed Web of Science ®Google Scholar
• Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(−/−) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2000;278:G829–G833.
   PubMed Web of Science ®Google Scholar
• Dijkstra G, Moshage H, van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, et al. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 1998;186: 416–421.
   PubMed Web of Science ®Google Scholar
• Godkin AJ, De Belder AJ, Villa L, Wong A, Beesley JE, Kane SP, Martin JF. Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest 1996; 26:867–872.
   PubMed Web of Science ®Google Scholar
• Ikeda I, Kasajima T, Ishiyama S, Shimojo T, Takeo Y, Nishikawa T, et al. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol 1997; 92:1339–1341.
   PubMed Web of Science ®Google Scholar